Genentech is the first biotechnology company to scale up protein manufacturing successfully from the small quantities used for research to the much larger quantities needed for clinical trials and marketing. This is in large part due to our Pharma Technical North America (PTNA) Operations group.
PTNA Operations turns cells into the final medicine that is delivered to patients, managing all aspects of manufacturing and supply, including quality, engineering and supply chain. These functions support Genentech's end-to-end process, which consists of two primary operations:
During all phases of this process, our goal is clear: support Genentech's business sustainability with uninterrupted supply to patients while meeting quality and compliance requirements as efficiently as possible.
Today, the combined organization of Genentech and Roche is a world leader in biologics manufacturing, with more FDA-approved manufacturing capacity for the production of biotech medicines than any other company.
Tim Moore, Global Head of Technical Operations, explains what it takes to make a biologic medicine.
Explore the technically complex and surprisingly beautiful world of manufacturing.